Feedback / Questions
Cosentyx (secukinumab) - Novartis
Cosentyx: Completion of P3b trial (NCT03504852) for psoriasis in H2 2020
(Novartis)
-
Oct 22, 2019 -
Q3 2019 Results: Completion of P3 MATURE trial (NCT03589885) for psoriasis in H2 2020
Trial completion date
https://www.novartis.com/sites/www.novartis.com/files/q3-2019-ir-presentation.pdf
Oct 22, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious